140 related articles for article (PubMed ID: 30169477)
1. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy.
Chen Y; Xu S; Wang Z; Zhao M; Wang H; Lu T; Zhao L
Ther Drug Monit; 2018 Dec; 40(6):730-737. PubMed ID: 30169477
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
3. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients.
Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157
[TBL] [Abstract][Full Text] [Related]
5. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.
He DK; Wang L; Qin J; Zhang S; Lu W; Li L; Zhang JM; Bao WQ; Song XQ; Liu HT
Acta Pharmacol Sin; 2012 Nov; 33(11):1417-23. PubMed ID: 23103620
[TBL] [Abstract][Full Text] [Related]
7. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
8. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L
Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400
[TBL] [Abstract][Full Text] [Related]
10. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis.
Lin WW; Wang CL; Jiao Z; Yu XL; Zhang J; Zhang WB; Lin RF; Lin S; Lin XH
Ther Drug Monit; 2019 Oct; 41(5):665-673. PubMed ID: 31033858
[TBL] [Abstract][Full Text] [Related]
11. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
[TBL] [Abstract][Full Text] [Related]
12. Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy.
Ortega-Vázquez A; Fricke-Galindo I; Dorado P; Jung-Cook H; Martínez-Juárez IE; Monroy-Jaramillo N; Rojas-Tomé IS; Peñas-Lledó E; Llerena A; López-López M
Pharmacogenomics J; 2020 Dec; 20(6):845-856. PubMed ID: 32483200
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I
Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
[TBL] [Abstract][Full Text] [Related]
15. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.
Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B
Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737
[TBL] [Abstract][Full Text] [Related]
16. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
[TBL] [Abstract][Full Text] [Related]
17. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
[TBL] [Abstract][Full Text] [Related]
18. Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy.
Wang ZZ; Zhang YF; Huang WC; Wang XP; Ni XJ; Lu HY; Hu JQ; Deng SH; Zhu XQ; Xie HS; Chen HZ; Zhang M; Qiu C; Wen YG; Shang DW
Front Pharmacol; 2019; 10():832. PubMed ID: 31404235
[TBL] [Abstract][Full Text] [Related]
19. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
Shen C; Zhang B; Liu Z; Tang Y; Zhang Y; Wang S; Guo Y; Ding Y; Wang S; Ding M
Seizure; 2017 Oct; 51():102-106. PubMed ID: 28837897
[TBL] [Abstract][Full Text] [Related]
20. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N
Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
